|
Prothrombin Gene Mutation
|
|
General
|
| |
Clinical Use:
|
This assay is used to determine the Prothrombin G20210A gene mutation status.
Patients heterozygous for the prothrombin G20210A mutation have an approximate 3 fold increased risk of thrombosis. This risk is significantly increased in homozygous patients. |
| |
Availability:
|
Samples are batched and tested once a week.
Please contact testing laboratory for urgent requests. |
| |
Aliases/Synonyms:
| 20210 Mutation, Factor II Prothrombin Gene Mutation, PGM, |
| |
Code:
|
HFIIP |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
Results are reported as homozygous, heterozygous or not detected for the Prothrombin G20210A gene mutation
|
Collection Requirements
|
| |
Container:
|
EDTA (LAVENDER), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
3ml |
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
| |
Processing Instructions:
|
|
| |
Minimum Assay Volume:
|
1ml |
| |
Stability:
|
15 days chilled |
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Coagulation |
Haematology |
Fiona Stanley Hospital |
6152 8135 |
|
Last Updated : 01-03-2022 15:18 |